| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Camurus AB (publ) (ST: CAMX)
CAMX Technical Analysis
3
| As on 10th Nov 2025 CAMX STOCK Price closed @ 624.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 611.55 & Buy for SHORT-TERM with Stoploss of 613.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CAMXSTOCK Price
| Open | 571.00 | Change | Price | % |
| High | 630.00 | 1 Day | 79.50 | 14.59 |
| Low | 571.00 | 1 Week | 1.50 | 0.24 |
| Close | 624.50 | 1 Month | -46.00 | -6.86 |
| Volume | 301684 | 1 Year | 76.50 | 13.96 |
| 52 Week High 733.50 | 52 Week Low 505.00 | ||||
ST Sweden Most Active Stocks
| ENERS | 0.00 | % |
| LIPI | 0.22 | -4.35% |
| SBB-B | 4.35 | -8.23% |
| WYLD | 0.01 | 0.00% |
| LUNE | 21.97 | 6.65% |
| POLY | 0.04 | 0.00% |
| EURA | 0.01 | 0.00% |
| SOLT | 0.22 | 0.00% |
| QUIA | 0.00 | % |
| AMNI | 0.01 | % |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| CAMX Daily Charts |
CAMX Intraday Charts |
Whats New @ Bazaartrend |
CAMX Free Analysis |
|
|
CAMX Important Levels Intraday
| RESISTANCE | 738.19 |
| RESISTANCE | 701.73 |
| RESISTANCE | 679.19 |
| RESISTANCE | 656.66 |
| SUPPORT | 592.35 |
| SUPPORT | 569.81 |
| SUPPORT | 547.27 |
| SUPPORT | 510.81 |
CAMX Forecast November 2025
| 4th UP Forecast | 954.98 |
| 3rd UP Forecast | 848.99 |
| 2nd UP Forecast | 783.48 |
| 1st UP Forecast | 717.97 |
| 1st DOWN Forecast | 531.03 |
| 2nd DOWN Forecast | 465.52 |
| 3rd DOWN Forecast | 400.01 |
| 4th DOWN Forecast | 294.02 |
CAMX Weekly Forecast
| 4th UP Forecast | 765.17 |
| 3rd UP Forecast | 720.06 |
| 2nd UP Forecast | 692.17 |
| 1st UP Forecast | 664.29 |
| 1st DOWN Forecast | 584.72 |
| 2nd DOWN Forecast | 556.83 |
| 3rd DOWN Forecast | 528.94 |
| 4th DOWN Forecast | 483.83 |
CAMX Forecast2025
| 4th UP Forecast | 1146.14 |
| 3rd UP Forecast | 978.85 |
| 2nd UP Forecast | 875.44 |
| 1st UP Forecast | 772.03 |
| 1st DOWN Forecast | 476.97 |
| 2nd DOWN Forecast | 373.56 |
| 3rd DOWN Forecast | 270.15 |
| 4th DOWN Forecast | 102.86 |
Camurus AB (publ) ( ST Sweden Symbol : CAMX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CAMX Business Profile
Camurus AB (publ), a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; and episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity. Its products pipeline also includes Brixadi for opioid dependence; CAM2038 that is in phase III clinical trials for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors; and CAM2043 that is in Phase II clinical trials for treatment of pulmonary arterial hypertension and Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which has completed Phase I clinical trials for the treatment of Endocrine disorder; CAM4083 for treatment of myasthenia gravis and other serious tissue-based complement-mediated disorders; CAM2047 for the treatment of chemotherapy induced nausea and vomiting; and CAM2048 for postoperative pain. The company was founded in 1991 and is headquartered in Lund, Sweden. Address: Ideon Science Park, Lund, Sweden, 223 70
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service